Investigating infections in critically ill patients on continuous renal replacement therapy
Official title: The Effect of Filter Lifespan in Continuous Renal Replacement Therapy on the Rate of New Infections in Critically Ill Patients: a Prospective, Multicenter, Observational Trial
Run by University Hospital Muenster · NCT05450185 · Data updated 2026-11-12
This study looks at critically ill patients on a special kidney treatment to see how often they get new infections and what might cause them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | University Hospital Muenster Academic / other |
| Locations | 5 sites (Innsbruck and 4 other locations) |
| Status | Recruiting |
| Started | March 2, 2023 |
| Main results expected | May 2025 |
| Study ends | August 2025 |
| Registry record updated | December 12, 2024 |
| Trial ID | NCT05450185 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adult patients aged 18 and older who are critically ill with dialysis-dependent AKI and receiving CRRT.
✕Probably not a fit
Patients with chronic kidney disease, chronic dialysis dependency, or those with certain immunosuppressive conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on critically ill patients undergoing continuous renal replacement therapy (CRRT) for acute kidney injury (AKI). It aims to analyze the incidence and characteristics of new infections associated with CRRT, as well as the factors influencing these infections. The study is based on findings from a post-hoc analysis of the RICH trial, which suggested a link between filter lifespan and infection rates. By understanding these dynamics, the research seeks to improve patient outcomes in the ICU setting.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for infections in critically ill patients receiving CRRT.
How similar studies have gone: While there have been studies on CRRT, this specific investigation into the relationship between filter lifespan and infection rates is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age ≥18 years) * Critically ill patients with dialysis-dependent AKI * Continuous renal replacement therapy (CRRT) * Written informed consent Exclusion Criteria: * Chronic kidney disease with estimated glomerular filtration rate (eGFR)\<30ml/min/1.73m2 * Chronic dialysis dependency * Kidney transplant * (Glomerulo-)nephritis, interstitial nephritis, vasculitis * Patients on immunosuppression * Patients with chronic inflammatory diseases (e.g. arthritis, HIV, chronic hepatitis) * Persons with any kind of dependency on the investigator or employed by the sponsor or investigator
Where it's running
-
Univ.-Klinik Innsbruck
Innsbruck, Austria Recruiting -
Universidade de São Paulo
São Paulo, Brazil Recruiting -
Universitätsklinikum Erlangen-Nürnberg, Abteilung für Nephrologie und Hypertensiologie
Erlangen, Germany Recruiting -
Kliniken Maria Hilf, Klinik für Anästhesiologie und Operative Intensivmedizin
Mönchengladbach, Germany Recruiting -
University Hospital Muenster
Münster, Germany Recruiting
Study contacts
- Principal investigator: Alexander Zarbock, MD — University Hospital Münster
- Study coordinator: Alexander Zarbock, MD
- Email: zarbock@uni-muenster.de
- Phone: +49-251-8347252
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intra-Abdominal Pressure Changes During CRRT in Critically Ill Adults
This study tests how intra-abdominal pressure changes in critically ill adults on continuous renal replacement therapy using a bladder pressure measurement.
-
Transducer levelling errors in everyday ICU practice
In critically ill, vasopressor-treated adults with arterial and central venous lines, this study tests how small height differences in pressure transducers may lead to measurement errors that could affect treatment decisions.
-
Post-filter hematocrit calculation for adults on continuous renal replacement therapy
This will test whether a calculation can accurately predict post-filter hematocrit compared with machine-measured values in adults receiving continuous renal replacement therapy.
-
What predicts death in the ICU? Analyzing APACHE II in Colombian patients
This study tests how well the APACHE II score predicts ICU mortality in adults treated at a Colombian hospital.
-
Using parasternal intercostal muscle thickening to help decide when to stop mechanical ventilation
This trial will test whether adding a bedside ultrasound measurement of parasternal intercostal muscle thickening helps doctors decide when to take critically ill patients off mechanical ventilation to reduce reintubation.
-
Testing SGLT2 inhibitors for treating sepsis in adults
This study is testing if a new type of diabetes medication can help adults with sepsis recover better and feel safer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.